BackX4 Pharmaceuticals Overview
X4 Pharmaceuticals Inc

X4 Pharmaceuticals Discounted Cash Flow

DCF Analysis for XFOR.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$2.66

Current Fair Value

$2.66
33.6% Downside

Overvalued by 33.6% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading